Monitoring anticoagulation during percutaneous coronary interventions
Author:
- 1 January 1995
- journal article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 1 (3) , 285-288
Abstract
Monitoring of the activated clotting time in the interventional catheterization suite is essential to minimize the risk of acute thrombotic occlusion, as well as to minimize the risk of bleeding-related complications postprocedure. Based on the technique used, a Hemochron ACT of >400 seconds or a HemoTec ACT of >300 seconds is associated with a low risk of acute thrombotic occlusion. Avoiding an ACT of >500 seconds should minimize the risk of procedure-related bleeding complications.Keywords
This publication has 13 references indexed in Scilit:
- Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplastyJACC, 1994
- Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplastyJACC, 1994
- Preprocedural anticoagulation does not reduce angioplasty heparin requirementsAmerican Heart Journal, 1993
- Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.Circulation, 1993
- Prothrombin fragment F1 + 2 concentrations for monitoring anticoagulation therapy with heparinInternational Journal of Cardiology, 1993
- Activated clotting times and activated partial thromboplastin times in patients undergoing coronary angioplasty who receive bolus doses of heparinCatheterization and Cardiovascular Diagnosis, 1992
- Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty.Heart, 1990
- Adequate heparinization during PTCA: Assessment using activated clotting timesCatheterization and Cardiovascular Diagnosis, 1989
- Adequate Anticoagulation During Cardiopulmonary Bypass Determined by Activated Clotting Time and the Appearance of Fibrin MonomerThe Annals of Thoracic Surgery, 1978
- Activated Coagulation Time of Whole BloodJAMA, 1966